» Articles » PMID: 39552787

Development of Novel Osteoarthritis Therapy by Targeting AMPK-β-catenin-Runx2 Signaling

Overview
Journal Genes Dis
Date 2024 Nov 18
PMID 39552787
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a debilitating chronic joint disease affecting large populations of patients, especially the elderly. The pathological mechanisms of OA are currently unknown. Multiple risk factors are involved in OA development. Among these risk factors, alterations of mechanical loading in the joint leading to changes in biological signaling pathways have been known as a key event in OA development. The importance of AMPK-β-catenin-Runx2 signaling in the initiation and progression of OA has been recognized in recent years. In this review, we discuss the recent progress in understanding the role of this signaling pathway and the underlying interaction mechanisms during OA development. We also discuss the drug development aiming to target this signaling pathway for OA treatment.

References
1.
Jeon S . Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016; 48(7):e245. PMC: 4973318. DOI: 10.1038/emm.2016.81. View

2.
Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M . Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol. 2001; 153(1):87-100. PMC: 2185519. DOI: 10.1083/jcb.153.1.87. View

3.
He M, Lu B, Opoku M, Zhang L, Xie W, Jin H . Metformin Prevents or Delays the Development and Progression of Osteoarthritis: New Insight and Mechanism of Action. Cells. 2022; 11(19). PMC: 9563728. DOI: 10.3390/cells11193012. View

4.
Tetsunaga T, Nishida K, Furumatsu T, Naruse K, Hirohata S, Yoshida A . Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells. Osteoarthritis Cartilage. 2010; 19(2):222-32. DOI: 10.1016/j.joca.2010.11.004. View

5.
Zeng L, Wang W, Rong X, Zhong Y, Jia P, Zhou G . Chondroprotective effects and multi-target mechanisms of Icariin in IL-1 beta-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis model. Int Immunopharmacol. 2013; 18(1):175-81. DOI: 10.1016/j.intimp.2013.11.021. View